We catch up with editorial board member Willem Fibbe from Leiden University Medical Centre to discuss mesenchymal stromal cells and their therapeutic potential in the clinic.
1. What properties of mesenchymal stromal cells (MSCs) have led to the investigation of their therapeutic potential? (0:09)
2. What are the potential clinical applications of MSCs? (2:06)
3. What are the major practical challenges of using MSCs in clinical applications, and what regulatory issues must we consider? (4:28)
4. What have been the most important recent research developments in this field? (7:28)
Speaker disclosures: Willem Fibbe has nothing to disclose in relation to this video interview.
Filmed at the 23rd Annual Congress of the European Association of Hematology (EHA), Stockholm, Sweden, June 14–17 2018
